Medicare Enrolled
Dr. Paul Le, MD
Interventional Pain Medicine Physician · Austin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Le from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Le? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Le
Dr. Paul Le is an interventional pain medicine physician in Austin, TX, with 18 years in practice. Based on federal Medicare data, Dr. Le performed 3,780 Medicare services across 1,860 unique beneficiaries.
Between the years covered by Open Payments, Dr. Le received a total of $28,594 from 49 pharmaceutical and/or device companies across 1156 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Le is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 24% volume in TX$ $28,594 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,780
Medicare services
Top 24% in TX for interventional pain medicine physician
1,860
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~210 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Drug screening test | 854 | $60 | $600 |
| Office visit, established patient (30-39 min) | 673 | $94 | $380 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 672 | $190 | $600 |
| Dexamethasone injection (steroid) | 313 | $0 | $3 |
| Assessment of emotional or behavioral problems | 284 | $4 | $17 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 169 | $239 | $750 |
| Compounded drug, not otherwise classified | 106 | $262 | $349 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 96 | $73 | $290 |
| Office visit, established patient (20-29 min) | 95 | $67 | $267 |
| New patient office visit (45-59 min) | 61 | $120 | $490 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 55 | $101 | $735 |
| Insertion of spinal neurostimulator electrode array through skin | 45 | $239 | $6,649 |
| Injection of substance into lower spine canal using imaging guidance | 42 | $69 | $787 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 35 | $93 | $526 |
| Joint injection, major joint | 30 | $63 | $187 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 30 | $52 | $270 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 25 | $105 | $573 |
| New patient office visit (30-44 min) | 23 | $85 | $328 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 22 | $61 | $289 |
| Office visit, established patient (10-19 min) | 22 | $42 | $164 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 19 | $78 | $489 |
| Injection of substance into middle or upper spine canal using imaging guidance | 19 | $82 | $798 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 19 | $209 | $1,245 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 17 | $64 | $517 |
| Insertion of spinal neurostimulator generator or receiver | 16 | $182 | $1,051 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 14 | $153 | $475 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 12 | $201 | $1,257 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 12 | $72 | $567 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.5% high complexity
17.2% medium
80.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$28,594
Total received (2018-2024)
Avg $4,085/year across 7 years
Top 14% in TX for interventional pain medicine physician
49
Companies
1,156
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,594 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,347
2023$3,219
2022$6,603
2021$4,724
2020$1,460
2019$2,809
2018$4,430
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$14,561
Boston Scientific Corporation
$6,230
Collegium Pharmaceutical, Inc.
$745
BOSTON SCIENTIFIC CORPORATION
$726
Medtronic, Inc.
$637
Nevro Corp.
$530
ABBVIE INC.
$525
Nalu Medical, Inc.
$496
PFIZER INC.
$470
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$359
Lundbeck LLC
$271
Amgen Inc.
$254
Novartis Pharmaceuticals Corporation
$241
AbbVie Inc.
$201
AstraZeneca Pharmaceuticals LP
$200
Biohaven Pharmaceutical Holding Company Ltd.
$194
Egalet US Inc
$176
US WorldMeds, LLC
$137
Medtronic USA, Inc.
$134
Teva Pharmaceuticals USA, Inc.
$123
Penumbra, Inc.
$109
UPSHER-SMITH LABORATORIES LLC
$100
RedHill Biopharma Inc.
$89
GRT US Holding, Inc.
$86
Lilly USA, LLC
$85
Forte Bio-Pharma LLC
$81
JAZZ PHARMACEUTICALS INC.
$74
Azurity Pharmaceuticals, Inc.
$72
Daiichi Sankyo Inc.
$62
Scilex Pharmaceuticals Inc.
$62
ARBOR PHARMACEUTICALS, INC.
$62
Supernus Pharmaceuticals, Inc.
$57
Assertio Therapeutics, Inc.
$48
Horizon Pharma plc
$40
BioDelivery Sciences International, Inc.
$37
IBSA Pharma Inc.
$34
TerSera Therapeutics LLC
$32
Shionogi Inc
$32
Currax Pharmaceuticals LLC
$29
Bioventus LLC
$28
Pernix Therapeutics Holdings, Inc.
$26
Averitas Pharma Inc.
$22
Biohaven Pharmaceuticals, Inc.
$22
Allergan, Inc.
$19
Kaleo, Inc.
$17
IMPEL PHARMACEUTICALS INC.
$15
Purdue Pharma L.P.
$14
Radius Health, Inc.
$13
Flexion Therapeutics, Inc.
$11
Top 3 companies account for 75.3% of total payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · AIMOVIG · AJOVY · APOKYN · AVISTA · Aimovig · Axium INS DRG IPG · BELBUCA · BUNAVAIL 2.1 mg 30-count box · Belbuca · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · Cambia · Durolane · EMGALITY · EXCLAIM · Evzio · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · HORIZANT · Horizant · IMFINZI · INTELLIS · INTELLIS ADAPTIVESTIM · Indigo System · LINEAR · LYRICA · Licart · MEDTRONIC REUSABLE INSTRUMENTS · MOVANTIK · MYOBLOC · Morphabond ER · Movantik · NURTEC ODT · Nalocet · Nalu Neurostimulation System · No Associated Product · Nucynta · OCTRODE · ONZETRA XSAIL · Octrode SCS Leads · Omnia · PENNSAID · PENTA · PRIALT · PROCLAIM · PRODIGY · PROLATE · PROTG · Penta SCS Leads · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · QUTENZA · Qutenza · RELISTOR · RYLAZE · SCS IPGs · SPECTRA WAVEWRITER · SPRIX · SWIFT-LOCK · SYMPROIC · SYNCHROMEDII · Senza Spinal Cord Stimulation System · SlimTip lead DRG Lead · Swift-Lock SCS · Symproic · TOSYMRA · TROKENDI XR · Tirosint · Tripole SCS Leads · Trudhesa · Tymlos · UBRELVY · VANTA ADAPTIVESTIM · VYEPTI · WAVEWRITER ALPHA · XTAMPZA · XTAMPZAER · XYWAV · Xtampza ER · ZEMBRACE SYMTOUCH · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $756 per 100 Medicare services performed
Geographic Context
Interventional Pain Medicine Physicians within 10 mi
10
Per 100K population
0.8
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Le is a clinical cardiology specialist, with above-average Medicare volume (top 24% in TX), and high industry engagement (low-engagement, top 14%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Le experienced with drug screening test?
Based on Medicare claims data, Dr. Le performed 854 drug screening test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Le receive payments from pharmaceutical companies?
Yes. Dr. Le received a total of $28,594 from 49 companies across 1,156 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Le's costs compare to other interventional pain medicine physicians in Austin?
Dr. Le's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Le) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Austin
Browse interventional pain medicine physicians in Austin ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in TX
Interventional Pain Medicine Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in TX
Which TX interventional pain medicine physicians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology